Individuals with cancer face unique risk factors for osteoporosis and fractures. Clinicians
must consider the additive effects of cancer-specific factors, including treatment-induced …

Fragility fracture is a worldwide problem and a main cause of disability and impaired quality
of life. It is primarily caused by osteoporosis, characterized by impaired bone quantity and or …

Simple Summary Thyroid-stimulating hormone (TSH) plays a role in the regulation of thyroid
hormones and is an important indicator for assessing thyroid function. Thyroid cancer (TC) is …

Currently, thyroid hormone status is predominantly determined by the measurement of
serum thyroid-stimulating hormone and free thyroxine. Although it is assumed that serum …

Postoperative hypoparathyroidism (PO‐hypoPT) is an uncommon complication of total
thyroidectomy in thyroid cancer patients. Although long‐term hypoPT causes characteristic …

Background: Long-term management of intermediate-and high-risk differentiated thyroid
cancer (DTC) involves thyrotropin (TSH) suppression with thyroid hormone to prevent …

Bone marrow contains resident cellular components that are not only involved in bone
maintenance but also regulate hematopoiesis and immune responses. The immune system …

Background: Despite a good prognosis, survivors of differentiated thyroid cancer (DTC) may
have reduced health-related quality of life (HRQOL) many years after treatment, and it is …

Purpose This study aimed to evaluate the effects of thyroid-stimulating hormone (TSH)
suppressive therapy on bone mineral density (BMD) and bone turnover markers (BTMs) in …

Thyroid hormones play an important physiological role in maintaining adult bone structure
and strength. Consequently, thyroid dysfunction is related to skeletal outcomes. Overt …